Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Antibody and Antigen Prevalence as Indicators of Ongoing Transmission or Elimination of Visceral Leishmaniasis: A Modeling StudyLuc E Coffeng, Epke A Le Rutte, Johanna Munoz, et al.
Parasites & Vectors|June 13, 2020
Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysisNatalie V S Vinkeles Melchers, Luc E Coffeng, Sake J de Vlas, et al.
Plos Neglected Tropical Diseases|July 3, 2020
The potential impact of human visceral leishmaniasis vaccines on population incidenceEpke A Le Rutte, Luc E Coffeng, Stefano Malvolti, et al.
NPJ Primary Care Respiratory Medicine|May 16, 2024
Tobacco control policies and respiratory conditions among children presenting in primary careTimor Faber, Luc E Coffeng, Aziz Sheikh, et al.
Psychoneuroendocrinology|February 9, 2007
Cortisol and severe fatigue: a longitudinal study in adolescent girlsMaike Ter Wolbeek, Lorenz J P van Doornen, Luc E Coffeng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2021
Impact of Key Assumptions About the Population Biology of Soil-Transmitted Helminths on the Sustainable Control of MorbidityCarolin Vegvari, Federica Giardina, Veronica Malizia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2024
Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian SettingsAnanthu James, Luc E Coffeng, David J Blok, et al.
Plos One|December 30, 2014
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatmentLuc E Coffeng, Wilma A Stolk, Achim Hoerauf, et al.
Plos Neglected Tropical Diseases|July 7, 2025
Target product profiles for new diagnostics to inform strongyloidiasis control programsAdama Kazienga, Luc E Coffeng, Sara Roose, et al.
American Journal of Epidemiology|May 8, 2019
Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African OnchocerciasisLuc E Coffeng, Wilma A Stolk, Allison Golden, et al.
Pageof 10